Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1526) 1526
Book Chapter (59) 59
Conference Proceeding (9) 9
Dissertation (6) 6
Publication (2) 2
Journal / eJournal (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
in-stent restenosis (1344) 1344
science & technology (960) 960
life sciences & biomedicine (901) 901
humans (842) 842
cardiovascular system & cardiology (681) 681
male (647) 647
stents (601) 601
cardiac & cardiovascular systems (575) 575
female (569) 569
middle aged (508) 508
aged (485) 485
stent (445) 445
treatment outcome (400) 400
drug-eluting stents (295) 295
coronary angiography (291) 291
time factors (223) 223
risk factors (218) 218
coronary restenosis - etiology (212) 212
coronary restenosis - diagnostic imaging (206) 206
drug-eluting stent (204) 204
cardiovascular (196) 196
percutaneous coronary intervention (194) 194
coronary restenosis - therapy (190) 190
follow-up studies (188) 188
retrospective studies (168) 168
stents - adverse effects (163) 163
biological and medical sciences (156) 156
medical sciences (155) 155
peripheral vascular disease (144) 144
restenosis (144) 144
recurrence (141) 141
angioplasty (140) 140
prosthesis design (138) 138
cardiology (135) 135
prospective studies (127) 127
in‐stent restenosis (126) 126
coronary heart disease (119) 119
percutaneous coronary intervention - adverse effects (115) 115
angioplasty, balloon, coronary - adverse effects (114) 114
analysis (112) 112
angioplasty, balloon, coronary - instrumentation (105) 105
optical coherence tomography (105) 105
animals (104) 104
surgery (104) 104
coronary artery disease (102) 102
aged, 80 and over (100) 100
percutaneous coronary intervention - instrumentation (100) 100
medicine & public health (94) 94
coronary artery disease - therapy (93) 93
coronary restenosis - prevention & control (92) 92
cardiology. vascular system (89) 89
coronary restenosis - diagnosis (87) 87
implants (86) 86
radiotherapy. instrumental treatment. physiotherapy. reeducation. rehabilitation, orthophony, crenotherapy. diet therapy and various other treatments (86) 86
transluminal angioplasty (86) 86
sirolimus - administration & dosage (85) 85
adult (83) 83
drug-eluting balloon (81) 81
angioplasty, balloon, coronary (80) 80
paclitaxel - administration & dosage (80) 80
cardiovascular agents - administration & dosage (79) 79
cardiovascular diseases (77) 77
radiology, nuclear medicine & medical imaging (77) 77
care and treatment (76) 76
drug-eluting stents - adverse effects (76) 76
angiography (73) 73
paclitaxel (71) 71
technology (71) 71
cardiology and cardiovascular medicine (70) 70
coronary vessels - pathology (70) 70
coronary restenosis - pathology (69) 69
predictive value of tests (69) 69
angioplasty, balloon, coronary - methods (68) 68
ultrasonography, interventional (68) 68
coated materials, biocompatible (67) 67
stenosis (66) 66
surgical implants (66) 66
brachytherapy (65) 65
heart (64) 64
risk assessment (64) 64
thrombosis (64) 64
drug-coated balloon (63) 63
medical imaging (63) 63
patients (63) 63
stent thrombosis (63) 63
atherosclerosis (62) 62
prosthesis failure (61) 61
intravascular ultrasound (60) 60
registries (60) 60
vascular patency (60) 60
angioplasty, balloon - instrumentation (59) 59
coronary angiography - methods (58) 58
coronary vessels (58) 58
coronary vessels - diagnostic imaging (58) 58
cardiovascular disease (57) 57
graft occlusion, vascular - diagnostic imaging (54) 54
metals (54) 54
multivariate analysis (54) 54
abridged index medicus (53) 53
coronary restenosis - radiotherapy (53) 53
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1529) 1529
Japanese (29) 29
German (18) 18
French (13) 13
Portuguese (10) 10
Chinese (9) 9
Polish (8) 8
Korean (6) 6
Italian (5) 5
Russian (3) 3
Czech (2) 2
Hungarian (2) 2
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Reducing in-stent restenosis: Therapeutic manipulation of miRNA in vascular remodeling and inflammation
by McDonald, Robert A and Halliday, Crawford A and Miller, Ashley M and Diver, Louise A and Dakin, Rachel S and Montgomery, Jennifer and McBride, Martin W and Kennedy, Simon and McClure, John D and Robertson, Keith E and Douglas, Gillian and Channon, Keith M and Oldroyd, Keith G and Baker, Andrew H
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2015, Volume 65, Issue 21, pp. 2314 - 2327
late stent thrombosis | miRNA stem loop | smooth muscle cell | neointima | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Vascular System Injuries - metabolism | Drug-Eluting Stents | Inflammation - metabolism | Vascular Remodeling | Animals | Swine | Coronary Restenosis - prevention & control | Male | MicroRNAs - metabolism | Coronary Restenosis - metabolism | Mice, Knockout | Inflammation | MicroRNA | Health aspects | Analysis | Stent (Surgery) | Index Medicus | Abridged Index Medicus | ISR, in-stent restenosis | miRNA stem loop | WT, wild-type | RNA, ribonucleic acid | BMDM, bone marrow–derived macrophages | PPAR, peroxisome proliferator–activated receptor | miRNA, micro–ribonucleic acid | PDCD4, programmed cell death protein 4 | BMS, bare-metal stent(s) | SMC, smooth muscle cell | CD, cluster of differentiation | KO, knockout | IL, interleukin | DES, drug-eluting stent(s) | LPS, lipopolysaccharide | PDGF, platelet-derived growth factor | Original Investigation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Current Treatment of In-Stent Restenosis
by Alfonso, Fernando, MD, PhD and Byrne, Robert A., MB, BCh, PhD and Rivero, Fernando, MD and Kastrati, Adnan, MD
Journal of the American College of Cardiology, ISSN 0735-1097, 2014, Volume 63, Issue 24, pp. 2659 - 2673
Cardiovascular | Internal Medicine | intravascular ultrasound | drug-eluting stents | in-stent restenosis | optical coherence tomography | drug-coated balloons | bare-metal stents | neoatherosclerosis | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | Medical sciences | Coronary Restenosis - diagnosis | Animals | Randomized Controlled Trials as Topic - methods | Humans | Treatment Outcome | Clinical Trials as Topic - methods | Randomized Controlled Trials as Topic - trends | Coronary Restenosis - therapy | Drug-Eluting Stents - adverse effects | Stent (Surgery) | Intervention | Heart attacks | Medical imaging | Angioplasty | Classification | Clinical trials | Radiation therapy | Intubation | Clinical medicine | Acute coronary syndromes | Stents | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents. The ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) Study
by Mehilli, Julinda and Byrne, Robert A and Tiroch, Klaus and Pinieck, Susanne and Schulz, Stefanie and Kufner, Sebastian and Massberg, Steffen and Laugwitz, Karl-Ludwig and Schömig, Albert and Kastrati, Adnan and ISAR-DESIRE 2 Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2010, Volume 55, Issue 24, pp. 2710 - 2716
drug-eluting stent | in-stent restenosis | randomized trial | resistance | sirolimus | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Heart | Cardiovascular system | Biological and medical sciences | Medical sciences | Antibacterial agents | Coronary heart disease | Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) | Cardiology. Vascular system | Radiodiagnosis. Nmr imagery. Nmr spectrometry | Investigative techniques, diagnostic techniques (general aspects) | Diseases of the cardiovascular system | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Coronary Restenosis - surgery | Drug-Eluting Stents | Paclitaxel - pharmacology | Follow-Up Studies | Humans | Myocardial Revascularization - methods | Male | Treatment Outcome | Secondary Prevention | Coronary Restenosis - diagnostic imaging | Sirolimus - pharmacology | Coronary Angiography | Female | Aged | Retrospective Studies | Antineoplastic Agents, Phytogenic - pharmacology | Immunosuppressive Agents - pharmacology | Heart attacks | Angioplasty | Stents | Coronary vessels | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: Initial results from the EXCITE ISR Trial (EXCImer laser randomized controlled study for treatment of FemoropopliTEal in-stent restenosis)
by Dippel, Eric J and Makam, Prakash and Kovach, Richard and George, Jon C and Patlola, Raghotham and Metzger, D. Christopher and Mena-Hurtado, Carlos and Beasley, Robert and Soukas, Peter and Colon-Hernandez, Pedro J and Stark, Matthew A and Walker, Craig and EXCITE ISR Investigators
JACC. Cardiovascular interventions, ISSN 1936-8798, 01/2015, Volume 8, Issue 1, pp. 92 - 101
Peripheral artery disease | In-stent restenosis | Percutaneous transluminal angioplasty | Excimer laser atherectomy | Randomized controlled trial | Femoropopliteal artery | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Recurrence | Peripheral Arterial Disease - surgery | Prospective Studies | Constriction, Pathologic | United States | Humans | Middle Aged | Male | Angioplasty, Balloon - adverse effects | Prosthesis Design | Atherectomy - mortality | Lasers, Excimer - therapeutic use | Atherectomy - methods | Time Factors | Popliteal Artery - physiopathology | Amputation | Laser Therapy - adverse effects | Female | Laser Therapy - methods | Popliteal Artery - surgery | Lasers, Excimer - adverse effects | Atherectomy - instrumentation | Stents | Limb Salvage | Femoral Artery - physiopathology | Alloys | Treatment Outcome | Combined Modality Therapy | Angioplasty, Balloon - instrumentation | Laser Therapy - mortality | Peripheral Arterial Disease - mortality | Peripheral Arterial Disease - therapy | Peripheral Arterial Disease - diagnosis | Angioplasty, Balloon - mortality | Aged | Laser Therapy - instrumentation | Chronic Disease | Femoral Artery - surgery | Atherectomy - adverse effects | Vascular Patency | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries
: Three-Year Results of the DEBATE-ISR Study
by Grotti, Simone and Liistro, Francesco and Angioli, Paolo and Ducci, Kenneth and Falsini, Giovanni and Porto, Italo and Ricci, Lucia and Ventoruzzo, Giorgio and Turini, Filippo and Bellandi, Guido and Bolognese, Leonardo
Journal of endovascular therapy, ISSN 1526-6028, 2/2016, Volume 23, Issue 1, pp. 52 - 57
Drug-coated balloon | Restenosis | Superficial femoral artery | Target lesion revascularization | Peripheral artery disease | In-stent restenosis | Popliteal artery | Diabetes | Femoropopliteal segment | Paclitaxel-eluting balloon | Stent | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Surgery | Science & Technology | Multivariate Analysis | Recurrence | Prospective Studies | Constriction, Pathologic | Humans | Middle Aged | Critical Illness | Male | Angioplasty, Balloon - adverse effects | Prosthesis Design | Diabetic Angiopathies - physiopathology | Time Factors | Popliteal Artery - physiopathology | Aged, 80 and over | Female | Registries | Retrospective Studies | Historically Controlled Study | Odds Ratio | Paclitaxel - administration & dosage | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Femoral Artery - physiopathology | Risk Factors | Kaplan-Meier Estimate | Ischemia - therapy | Logistic Models | Treatment Outcome | Ischemia - physiopathology | Chi-Square Distribution | Ischemia - diagnosis | Popliteal Artery - diagnostic imaging | Angioplasty, Balloon - instrumentation | Diabetic Angiopathies - therapy | Peripheral Arterial Disease - therapy | Peripheral Arterial Disease - physiopathology | Retreatment | Femoral Artery - diagnostic imaging | Peripheral Arterial Disease - diagnosis | Diabetic Angiopathies - diagnosis | Aged | Vascular Patency | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: Results of the restenosis cutting balloon evaluation trial (RESCUT)
by Albiero, Remo and Silber, Sigmund and Di Mario, Carlo and Cernigliaro, Carmelo and Battaglia, Salvatore and Reimers, Bernhard and Frasheri, Arian and Klauss, Volker and Auge, Joseph M and Rubartelli, Paolo and Morice, Marie-Claude and Cremonesi, Alberto and Schofer, Joachim and Bortone, Alessandro and Colombo, Antonio and RESCUT Invest and RESCUT Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2004, Volume 43, Issue 6, pp. 943 - 949
Major adverse cardiac events | CBA | Minimum lumen diameter | MLD | Creatine kinase | PTCA | In-stent restenosis | ISR | IVUS | Percent diameter stenosis | Intravascular ultrasound | DS | MACE | Cutting balloon angioplasty | CABG | Coronary artery bypass graft surgery | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Prospective Studies | Angioplasty, Balloon, Coronary - methods | Europe | Humans | Middle Aged | Male | Treatment Outcome | Coronary Restenosis - diagnostic imaging | Coronary Restenosis - pathology | Coronary Restenosis - therapy | Coronary Angiography | Coronary Restenosis - mortality | Female | Stents | Angioplasty, Balloon - methods | Angioplasty | Coronary vessels | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text In‐Stent Restenosis
by Kim, Michael S and Dean, Larry S
Cardiovascular therapeutics, ISSN 1755-5914, 06/2011, Volume 29, Issue 3, pp. 190 - 198
Stent restenosis | Drug‐eluting stent | Bare metal stent | In‐stent restenosis | In-stent restenosis | Drug-eluting stent | Cardiac & Cardiovascular Systems | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular system | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Humans | Risk Factors | Coronary Restenosis - prevention & control | Coronary Restenosis - physiopathology | Stents - adverse effects | Coronary Restenosis - etiology | Drug-Eluting Stents - adverse effects | Randomized Controlled Trials as Topic | Cardiology | Health aspects | Stent (Surgery) | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Stent thrombosis and restenosis: What have we learned and where are we going? the Andreas Grüntzig Lecture ESC 2014
by Byrne, Robert A and Joner, Michael and Kastrati, Adnan
European heart journal, ISSN 0195-668X, 12/2015, Volume 36, Issue 47, pp. 3320 - 3331
In-stent restenosis | Neoatherosclerosis | Stent thrombosis | Bioresorbable stents | Coronary artery disease | Drug-eluting stents | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Percutaneous Coronary Intervention - trends | Drug-Eluting Stents - trends | Humans | Middle Aged | Risk Factors | Graft Occlusion, Vascular - prevention & control | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Absorbable Implants | Drug-Eluting Stents - adverse effects | Graft Occlusion, Vascular - etiology | Prosthesis Failure | Coronary Thrombosis - prevention & control | Female | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Coronary Restenosis - etiology | Index Medicus | Reviews
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text In-Stent Restenosis in the Drug-Eluting Stent Era
by Dangas, George D., MD and Claessen, Bimmer E., MD and Caixeta, Adriano, MD and Sanidas, Elias A., MD and Mintz, Gary S., MD and Mehran, Roxana, MD
Journal of the American College of Cardiology, ISSN 0735-1097, 2010, Volume 56, Issue 23, pp. 1897 - 1907
Cardiovascular | Internal Medicine | in-stent restenosis | target lesion revascularization | drug-eluting stent(s) | Target lesion revascularization | In-stent restenosis | Drug-eluting stent(s) | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) | Drug-Eluting Stents | Humans | Brachytherapy - methods | Ultrasonography, Interventional |